Platelets are the smallest of the blood cells and are known to be activated
during cardiopulmonary bypass. They play a role in many associated complic
ations. Both quantitative and qualitative platelet defects have been demons
trated, resulting in microvascular hemorrhage and thromboembolism. As their
interactions with endothelium and other blood cells are unraveled, the imp
ortant contribution they make toward the systemic inflammatory response to
operation seen in cardiopulmonary bypass is increasingly evident. In this r
eview, we consider platelet activation during cardiopulmonary bypass, the r
esultant clinical effects, and potential approaches to therapy and preventi
on. (C) 1998 by The Society of Thoracic Surgeons.